Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Agreed. I'm sort of feeling like the trial organization and execution is a byproduct of general lack of sufficient economic backing. (which isn't an explanation of strange reporting or analysis)

I also am not quite understanding why targeting a specific partner who's articulated an interest, with specific interim desired-data, hasn't been happening.

SO much going on that makes zero sense to me related to how they're 'running this as a business'.

Goofy how they report median duration of SOM on the entire population of 21 subjects that received brilacidin, instead of just the 9 who got SOM. The duration of SOM for the 12 subjects who didn't get SOM was obviously 0, so the 0 statistic of median SOM duration across the brilacidin population is meaningless / not at all descriptive of the duration of SOM for those who actually received brilacidin and had SOM.

Likewise for the placebo group - why not report the median duration for only those who got SOM, not the entire group (which includes those who didn't get SOM)?